Morgan Stanley’s Heartflow Inc HTFL Stock Holding History

Morgan Stanley’s Portfolio HTFL Stock Details HTFL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31M	Buy	1,054,889 +202,957	+24%	+$6.1M	﹤0.01%	2692
2026 Q1	$20.7M	Buy	851,932 +106,008	+14%	+$2.88M	﹤0.01%	2926
2025 Q4	$21.7M	Sell	745,924 -9,217	-1%	-$297K	﹤0.01%	2863
2025 Q3	$25.4M	Buy	+755,141	New	+$24.3M	﹤0.01%	2656

Other funds holding HTFL

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Morgan Stanley's HTFL Position: Q2 2026 in Review

Morgan Stanley increased its Heartflow Inc (HTFL) stake by 24% in Q2 2026, buying an estimated $6.1M and bringing the position to 1,054,889 shares worth $31M. The position accounts for ﹤0.01% of the portfolio, ranked #2692.

Morgan Stanley first reported a position in HTFL in Q3 2025 and has held it in 4 quarters since. 193 funds tracked by Wall St. Rank hold HTFL as of Q2 2026.

Morgan Stanley held 1,054,889 shares of Heartflow Inc worth $31M as of Q2 2026.
Morgan Stanley bought 202,957 Heartflow Inc shares in Q2 2026, an estimated $6.1M.
Heartflow Inc made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #2692 holding.
Morgan Stanley first reported a position in Heartflow Inc in Q3 2025 and has held it in 4 quarters since.
193 funds tracked by Wall St. Rank held Heartflow Inc as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.